Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vigil Neuroscience, Inc. - Common Stock
(NQ:
VIGL
)
3.500
+0.010 (+0.29%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
159,294
Open
3.470
Bid (Size)
2.810 (1)
Ask (Size)
3.600 (93)
Prev. Close
3.490
Today's Range
3.330 - 3.630
52wk Range
2.470 - 9.240
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
VIGL Stock Earnings: Vigil Neuroscience Beats EPS for Q2 2024
August 13, 2024
VIGL stock results show that Vigil Neuroscience beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Vigil Neuroscience Reports Second Quarter 2024 Financial Results and Provides Business Update
August 13, 2024
From
Vigil Neuroscience, Inc.
Via
GlobeNewswire
Performance
YTD
+0.86%
+0.86%
1 Month
-5.91%
-5.91%
3 Month
+0.29%
+0.29%
6 Month
+12.54%
+12.54%
1 Year
-33.84%
-33.84%
More News
Read More
Vigil Neuroscience Highlights Publication on ALSP Genetic Mutation Prevalence in Neurology Genetics
August 01, 2024
From
Vigil Neuroscience, Inc.
Via
GlobeNewswire
Vigil Presents Data on its Small Molecule TREM2 Agonist Program at 2024 Alzheimer's Association International Conference (AAIC)
July 30, 2024
From
Vigil Neuroscience, Inc.
Via
GlobeNewswire
Vigil Neuroscience: Q4 Earnings Insights
March 26, 2024
Via
Benzinga
Small Neurodegenerative Disease-Focused Vigil Neuroscience Says Alzheimer's Candidate Shows Significant Impact On Disease Bimarker
July 24, 2024
Via
Benzinga
Vigil Neuroscience Announces Interim Data from its Ongoing Phase 1 Clinical Trial Evaluating VG-3927 in Healthy Volunteers Supporting Continued Development in Alzheimer’s Disease
July 24, 2024
From
Vigil Neuroscience, Inc.
Via
GlobeNewswire
Vigil Announces Upcoming Presentations on its Small Molecule TREM2 Agonist VG-3927 at the 2024 Alzheimer's Association International Conference
July 18, 2024
From
Vigil Neuroscience, Inc.
Via
GlobeNewswire
Vigil Neuroscience Provides Update on Clinical Development Strategy to Pursue Potential Accelerated Approval Pathway for Iluzanebart in ALSP
July 18, 2024
From
Vigil Neuroscience, Inc.
Via
GlobeNewswire
Why Is Tonix Pharmaceuticals (TNXP) Stock Down 33% Today?
June 27, 2024
Via
InvestorPlace
Why Is Branchout Food (BOF) Stock Down 39% Today?
June 27, 2024
Via
InvestorPlace
Why Is Vigil Neuroscience (VIGL) Stock Up 32% Today?
June 27, 2024
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
June 27, 2024
Via
InvestorPlace
Vigil Neuroscience Announces $40 Million Strategic Investment from Sanofi
June 27, 2024
From
Vigil Neuroscience, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
June 12, 2024
Via
Benzinga
3 Penny Stocks With the Power to 10X Your $1k Investment: June Edition
June 11, 2024
Via
InvestorPlace
3 Penny Stocks That Can Deliver Over 5,000% Upside by 2025: June Edition
June 11, 2024
Via
InvestorPlace
Vigil Neuroscience to Present in Upcoming June Investor Conferences
May 30, 2024
From
Vigil Neuroscience, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 08, 2024
Via
Benzinga
Vigil Neuroscience to Present at The Citizens JMP Life Sciences Conference
May 08, 2024
From
Vigil Neuroscience, Inc.
Via
GlobeNewswire
VIGL Stock Earnings: Vigil Neuroscience Beats EPS for Q1 2024
May 07, 2024
Via
InvestorPlace
Vigil Neuroscience Reports First Quarter 2024 Financial Results and Provides Business Update
May 07, 2024
From
Vigil Neuroscience, Inc.
Via
GlobeNewswire
Vigil Presents Key Findings from ILLUMINATE & IGNITE Studies in ALSP at the 2024 American Academy of Neurology Annual Meeting
April 17, 2024
From
Vigil Neuroscience, Inc.
Via
GlobeNewswire
VIGL Stock Earnings: Vigil Neuroscience Misses EPS for Q4 2023
March 26, 2024
Via
InvestorPlace
Vigil Neuroscience Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
March 26, 2024
From
Vigil Neuroscience, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.